Chemical firms see opportunity in biocatalysis

08/13/2013 | Motley Fool, The

BASF, Novozymes and DuPont are among the companies that see opportunities in biocatalysts -- natural catalysts such as enzymes. The market for these enzymes could reach $5 billion per year, according to this article. BASF now has pharmaceutical enzyme manufacturing lines in the U.S., India and Italy.

View Full Article in:

Motley Fool, The

Published in Brief: